ValuEngine upgraded shares of MedEquities Realty Trust (NYSE:MRT) from a hold rating to a buy rating in a report released on Friday morning.

Other analysts have also issued reports about the company. KeyCorp restated a buy rating and issued a $13.00 target price on shares of MedEquities Realty Trust in a research note on Tuesday, September 26th. B. Riley reiterated a buy rating on shares of MedEquities Realty Trust in a report on Wednesday, November 8th. Capital One Financial assumed coverage on MedEquities Realty Trust in a report on Monday, October 23rd. They issued an equal weight rating and a $13.00 price target on the stock. Zacks Investment Research upgraded MedEquities Realty Trust from a sell rating to a hold rating and set a $12.00 price target on the stock in a report on Wednesday, November 15th. Finally, Cantor Fitzgerald assumed coverage on MedEquities Realty Trust in a report on Thursday, August 31st. They issued an overweight rating and a $14.00 price target on the stock. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average price target of $12.83.

MedEquities Realty Trust (NYSE MRT) remained flat at $$11.22 during trading on Friday. The company’s stock had a trading volume of 147,620 shares, compared to its average volume of 228,358. MedEquities Realty Trust has a 52 week low of $10.06 and a 52 week high of $13.06. The stock has a market capitalization of $356.30 and a price-to-earnings ratio of 10.19.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.49%. The ex-dividend date of this dividend was Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio is currently 215.38%.

In other news, CEO John W. Mcroberts bought 18,000 shares of the company’s stock in a transaction that occurred on Friday, November 17th. The shares were acquired at an average price of $10.74 per share, with a total value of $193,320.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Randy L. Churchey bought 5,300 shares of the company’s stock in a transaction that occurred on Monday, November 20th. The stock was purchased at an average cost of $10.87 per share, for a total transaction of $57,611.00. Following the transaction, the director now owns 46,776 shares in the company, valued at approximately $508,455.12. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 23,600 shares of company stock worth $254,129. 2.50% of the stock is currently owned by insiders.

A number of institutional investors have recently made changes to their positions in MRT. Janney Montgomery Scott LLC boosted its stake in shares of MedEquities Realty Trust by 0.3% during the 2nd quarter. Janney Montgomery Scott LLC now owns 53,741 shares of the financial services provider’s stock worth $678,000 after acquiring an additional 175 shares during the period. Wells Fargo & Company MN boosted its stake in shares of MedEquities Realty Trust by 2.0% during the 2nd quarter. Wells Fargo & Company MN now owns 24,666 shares of the financial services provider’s stock worth $311,000 after acquiring an additional 482 shares during the period. Parametric Portfolio Associates LLC boosted its stake in shares of MedEquities Realty Trust by 4.4% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 40,531 shares of the financial services provider’s stock worth $512,000 after acquiring an additional 1,704 shares during the period. Dynamic Technology Lab Private Ltd boosted its stake in shares of MedEquities Realty Trust by 25.1% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 16,686 shares of the financial services provider’s stock worth $210,000 after acquiring an additional 3,346 shares during the period. Finally, IndexIQ Advisors LLC boosted its stake in shares of MedEquities Realty Trust by 11.7% during the 2nd quarter. IndexIQ Advisors LLC now owns 32,620 shares of the financial services provider’s stock worth $412,000 after acquiring an additional 3,410 shares during the period. 93.19% of the stock is currently owned by institutional investors and hedge funds.

WARNING: “MedEquities Realty Trust (MRT) Upgraded by ValuEngine to Buy” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://www.thecerbatgem.com/2017/12/02/medequities-realty-trust-mrt-upgraded-by-valuengine-to-buy.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Stock Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related stocks with our FREE daily email newsletter.